Insulet (PODD) Revenue (2016 - 2025)
Insulet's Revenue history spans 16 years, with the latest figure at $783.8 million for Q4 2025.
- For Q4 2025, Revenue rose 31.18% year-over-year to $783.8 million; the TTM value through Dec 2025 reached $2.7 billion, up 30.73%, while the annual FY2025 figure was $2.7 billion, 30.73% up from the prior year.
- Revenue reached $783.8 million in Q4 2025 per PODD's latest filing, up from $706.3 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $783.8 million in Q4 2025 to a low of $249.5 million in Q1 2021.
- Average Revenue over 5 years is $444.7 million, with a median of $414.6 million recorded in 2023.
- Peak YoY movement for Revenue: rose 13.06% in 2022, then surged 37.9% in 2023.
- A 5-year view of Revenue shows it stood at $327.0 million in 2021, then increased by 13.06% to $369.7 million in 2022, then soared by 37.9% to $509.8 million in 2023, then grew by 17.2% to $597.5 million in 2024, then soared by 31.18% to $783.8 million in 2025.
- Per Business Quant, the three most recent readings for PODD's Revenue are $783.8 million (Q4 2025), $706.3 million (Q3 2025), and $649.1 million (Q2 2025).